Summary
In HepG2 cells phosphorothioate modified antisense oligonucleotides against a sequence in the Ca2+ binding domain (AS-Ca2+) of type II sPLA2 mRNA restrained IL-6-induced synthesis of sPLA2 protein, sPLA2 mRNA (northern blot), and abolished IL-6 stimulated PGE2 release. An antisense oligonucleotide corresponding to a sequence in the catalytic domain (AS-Cat) of sPLA2 was less effective. The antisense oligonucleotides did not affect albumin synthesis in HepG2 cells, additionally demonstrating their specificity. The corresponding AS-Ca2+ against a homologous part of the rat sPLA2 mRNA depressed rat carrageenin oedema for 60–70%. Identical suppression was achieved by specific low molecular weight inhibitors of sPLA2. Since cyclo- and 5-lipoxygenase inhibitors exerted similar reductions of carrageenin oedema type II sPLA2 dependent eicosanoid formation seems to be a key cascade in this type of inflammation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Refferences
Dennis, E.A., 1994, Diversity of group types, regulation and function of phospholipase A2. J. Biol. Chem.269:13057–13060.
Murakami, M., Nakatani, Y., Atsumi, G., Inoue, K., and Kudo, I., 1997, Regulatory functions of phospholipase A2. Crit. Rev. Immunol.17:225–283.
Bonventre, J.V., Huang, Z., Taheri, M.R., O’Leary, E., Li, E., Moskowitz, M.A., Sapirstein, A., 1997, Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2, Nature390:622–625.
Uozumi, N., Kume, K., Nagase, T., Nakatani, N., Ishii, S., Tashiro, F., Komagata, Y., Maki, K., Ikuta, K., Ouchi, Y., Miyazaki, J., Shimizu, T., 1997, Role of cytosolic phospholipase A2 in allergic response and parturition. Nature390:618–622.
Tibes, U., and Friebe, W.G., 1997, Phospholipase A2 inhibitors in development. Exp. Opin. Invest. Drugs6:279–298.
Sapirstein, A., Spech, R., Witzgall, R., Bonventre, J.V., 1996, Cytosolic phospholipase A2 (PLA2), but not secretory PLA2, potentiates hydrogen peroxide cytotoxicity in kidney epithelial cells. J. Biol. Chem.271:21505–21513.
Hayakawa, M., Ishida, N., Takeuchi, K., Shibamoto, S., Hori, T., Oku, N., Ito, F., Tsujimoto, M., 1993, Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor J. Biol. Chem.268:11290–11295.
Wissing, D., Mouritzen, H., Egeblad, M., Poirier, G.G., Jäätelä, M., 1997, Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc. Nat. Acad. Sci. USA,94:5073–5077.
Macewan, D.J., 1996, Elevated cPLA2 levels as a mechanism by which the p70 TNF and p75 NGF receptors enhance apoptosis. FEBS-Letters379:77–81.
Rola-Pleszczynski, M., Stankova, J., 1992, Leukotriene B4 enhances interleukin-6 (IL-6) production and IL-6 messenger RNA accumulation in human monocytes in vitro: transcriptional and posttranscriptional mechanisms. Blood 80:1004–1011.
Poubelle, P.E., Gingras, D., Demers, C, Dubois, C, Harbour, D., Grassi, J., Rola-Pleszczynski, M., 1991, Platelet-activating factor (PAF-acether) enhances the concomittant production of tumor necrosis factor α and interleukin 1 production by subsets of human monocytes. Immunol.72:181–187.
Tibes, U., Vondran, A., Rodewald, E., Friebe, W.G., Schäfer, W., Scheuer, W., 1995, Inhibition of allergic and non-allergic inflammation by phospholipase A2 inhibitors. Int. Arch. Allergy. Immunol.107:432–434.
Amandi-Burgermeister, E., Tibes, U., Kaiser, B.M., Friebe, W.G., Scheuer, W.V., 1997, Suppression of cytokine synthesis, integrin expression and chronic inflammation by inhibitors of cytosolic phospholipase A2. Europ. J. Pharmacol.326:237–250.
Tibes, U., Scheuer, W.V., Thierse, H.J., Burgermeister, E., Schramm, S., Friebe, W.G., Dietz, E., 1997, Role of cytosolic PLA2, secretory PLA2 and nitric oxide synthase in inflammation. In: Phospholipase A2. Basic and Clinical Aspects in Inflamrnmatory Diseases. Eds Uhl, W., Nevalainen, T.J., Büchler, M.W., Progress in Surgery24: 153–167. Karger, Basel.
Baldie, G.D., Kaimakamis, D., Rotondo, D., 1993, Fatty acid modulation of cytokine release from human monocytic cells. Biochim. Biophys. Acta.1179:125–133.
Los, M., Baeuerle, P.A., 1995, IL-2 gene expression and NF-KB activation through CD28 requires reactive oxygen production by 15-lipoxygenase. EMBO J.14:3731–3740.
Rao, G.N., Lassegue, B., Griendling, K.K., Alexander, R.W., Berk, B.C., 1993, Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid release. Role of protein kinase C. Nucleic Acids Res.21:1259–1263.
Anderson, K.M., Roshak, A., Winkler, J.D., McCord, M., Marshall, L.A., 1997, Cytosolic 85-kDa phospholipase A2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells. J-Bio. Chem.272:30504–30511.
Marshall, L.L., Bolognese, B., Winkler, J.D., Roshak A., 1997, Depletion of human monocyte 85-kDa phospholipase A2 does not alter leukotriene formation. J. Biol Chem.272:759–765.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tibes, U., Röhr, S.P., Scheuer, W., Amandi-Burgermeister, E., Litters, A. (1999). Supression of Acute Experimental Inflammation by Antisense Oligonucleotides Targeting Secretory Phospholipase A2 (sPLA2)IN VITRO and IN VIVO Experiments. In: Honn, K.V., Marnett, L.J., Nigam, S., Dennis, E.A. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 4. Advances in Experimental Medicine and Biology, vol 469. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4793-8_30
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4793-8_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7171-7
Online ISBN: 978-1-4615-4793-8
eBook Packages: Springer Book Archive